Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma
- 21 March 2011
- journal article
- research article
- Published by Elsevier BV in Biomaterials
- Vol. 32 (18), 4293-4305
- https://doi.org/10.1016/j.biomaterials.2011.02.044
Abstract
No abstract availableFunding Information
- National Major Science and Technology Projects of China (2009ZX09310-006)
- National Natural Science Foundation of China (30873177)
- National Key Research and Development Program of China (2007CB935802)
This publication has 59 references indexed in Scilit:
- Targeted Imaging and Therapy of Brain Cancer Using Theranostic NanoparticlesMolecular Pharmaceutics, 2010
- Endocytosis of nanomedicinesJournal of Controlled Release, 2010
- Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast CancerPharmaceutical Research, 2009
- Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep‐2British Journal of Pharmacology, 2008
- Multifunctional magnetic nanoparticles for targeted imaging and therapy☆Advanced Drug Delivery Reviews, 2008
- Vincristine Induces Dramatic Lysosomal Changes and Sensitizes Cancer Cells to Lysosome-Destabilizing SiramesineCancer Research, 2007
- Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous SystemJournal of Cerebral Blood Flow & Metabolism, 2006
- Molecular mechanisms of lipoprotein receptor signallingCellular and Molecular Life Sciences, 2005
- Pharmacological Effects of Formulation VehiclesClinical Pharmacokinetics, 2003
- Spatial Organization of EGF Receptor Transmodulation by PDGFBiochemical and Biophysical Research Communications, 1999